Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.
Identifieur interne : 000691 ( PubMed/Corpus ); précédent : 000690; suivant : 000692Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.
Auteurs : P. Ladyzy Ski ; J M W Jcicki ; J. Krzymie ; J. Blachowicz ; E. J Wicka ; K. Czajkowski ; E. Janczewska ; W. KarnafelSource :
- The International journal of artificial organs [ 0391-3988 ] ; 2001.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Hypoglycemic Agents, Insulin.
- drug therapy : Diabetes Mellitus, Type 1, Pregnancy in Diabetics.
- Adult, Algorithms, Female, Humans, Pregnancy, Software, Telemedicine, Treatment Outcome, User-Computer Interface.
Abstract
A telematic system supporting intensive insulin treatment of pregnant type 1 diabetic out-clinic patients was implemented and technical efficiency of the system was evaluated over long-term ambulatory application. The system consists of a patient teletransmission module (PTM) and a central clinical control unit (CCU). The PTM contains a one-box blood glucose meter and electronic logbook, a modem and a dial-up or cellular phone set. The CCU consists of a PC computer with a modem and DIAPRET - an original program designed to monitor the intensive insulin treatment. The system was installed in the Clinic of Gastroenterology and Metabolic Disease, MA Warsaw and was tested for 166 +/- 24 days on 15 pregnant type 1 diabetic women. Telemonitoring of the patient data was done automatically. No major technical problems with proper operation or handling of the system was noted. Total effectiveness was 69.3 +/- 13.0% and technical effectiveness 91.5 +/- 6.1%. The efficacy of the system was not significantly influenced by patient intelligence level, education level or place of residence (p < 0.05). Significant improvement of metabolic control was noted during application of the system. In conclusion, the telematic system we developed and implemented should have a positive influence on the quality of diabetes treatment during pregnancy.
PubMed: 11314810
Links to Exploration step
pubmed:11314810Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.</title><author><name sortKey="Ladyzy Ski, P" sort="Ladyzy Ski, P" uniqKey="Ladyzy Ski P" first="P" last="Ladyzy Ski">P. Ladyzy Ski</name><affiliation><nlm:affiliation>Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw - Poland. Piotr.Ladyzynski@ibib.waw.pl</nlm:affiliation></affiliation></author><author><name sortKey="W Jcicki, J M" sort="W Jcicki, J M" uniqKey="W Jcicki J" first="J M" last="W Jcicki">J M W Jcicki</name></author><author><name sortKey="Krzymie, J" sort="Krzymie, J" uniqKey="Krzymie J" first="J" last="Krzymie">J. Krzymie</name></author><author><name sortKey="Blachowicz, J" sort="Blachowicz, J" uniqKey="Blachowicz J" first="J" last="Blachowicz">J. Blachowicz</name></author><author><name sortKey="J Wicka, E" sort="J Wicka, E" uniqKey="J Wicka E" first="E" last="J Wicka">E. J Wicka</name></author><author><name sortKey="Czajkowski, K" sort="Czajkowski, K" uniqKey="Czajkowski K" first="K" last="Czajkowski">K. Czajkowski</name></author><author><name sortKey="Janczewska, E" sort="Janczewska, E" uniqKey="Janczewska E" first="E" last="Janczewska">E. Janczewska</name></author><author><name sortKey="Karnafel, W" sort="Karnafel, W" uniqKey="Karnafel W" first="W" last="Karnafel">W. Karnafel</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2001">2001</date><idno type="RBID">pubmed:11314810</idno><idno type="pmid">11314810</idno><idno type="wicri:Area/PubMed/Corpus">000691</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000691</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.</title><author><name sortKey="Ladyzy Ski, P" sort="Ladyzy Ski, P" uniqKey="Ladyzy Ski P" first="P" last="Ladyzy Ski">P. Ladyzy Ski</name><affiliation><nlm:affiliation>Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw - Poland. Piotr.Ladyzynski@ibib.waw.pl</nlm:affiliation></affiliation></author><author><name sortKey="W Jcicki, J M" sort="W Jcicki, J M" uniqKey="W Jcicki J" first="J M" last="W Jcicki">J M W Jcicki</name></author><author><name sortKey="Krzymie, J" sort="Krzymie, J" uniqKey="Krzymie J" first="J" last="Krzymie">J. Krzymie</name></author><author><name sortKey="Blachowicz, J" sort="Blachowicz, J" uniqKey="Blachowicz J" first="J" last="Blachowicz">J. Blachowicz</name></author><author><name sortKey="J Wicka, E" sort="J Wicka, E" uniqKey="J Wicka E" first="E" last="J Wicka">E. J Wicka</name></author><author><name sortKey="Czajkowski, K" sort="Czajkowski, K" uniqKey="Czajkowski K" first="K" last="Czajkowski">K. Czajkowski</name></author><author><name sortKey="Janczewska, E" sort="Janczewska, E" uniqKey="Janczewska E" first="E" last="Janczewska">E. Janczewska</name></author><author><name sortKey="Karnafel, W" sort="Karnafel, W" uniqKey="Karnafel W" first="W" last="Karnafel">W. Karnafel</name></author></analytic><series><title level="j">The International journal of artificial organs</title><idno type="ISSN">0391-3988</idno><imprint><date when="2001" type="published">2001</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Algorithms</term><term>Diabetes Mellitus, Type 1 (drug therapy)</term><term>Female</term><term>Humans</term><term>Hypoglycemic Agents (therapeutic use)</term><term>Insulin (therapeutic use)</term><term>Pregnancy</term><term>Pregnancy in Diabetics (drug therapy)</term><term>Software</term><term>Telemedicine</term><term>Treatment Outcome</term><term>User-Computer Interface</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Hypoglycemic Agents</term><term>Insulin</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Diabetes Mellitus, Type 1</term><term>Pregnancy in Diabetics</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Algorithms</term><term>Female</term><term>Humans</term><term>Pregnancy</term><term>Software</term><term>Telemedicine</term><term>Treatment Outcome</term><term>User-Computer Interface</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A telematic system supporting intensive insulin treatment of pregnant type 1 diabetic out-clinic patients was implemented and technical efficiency of the system was evaluated over long-term ambulatory application. The system consists of a patient teletransmission module (PTM) and a central clinical control unit (CCU). The PTM contains a one-box blood glucose meter and electronic logbook, a modem and a dial-up or cellular phone set. The CCU consists of a PC computer with a modem and DIAPRET - an original program designed to monitor the intensive insulin treatment. The system was installed in the Clinic of Gastroenterology and Metabolic Disease, MA Warsaw and was tested for 166 +/- 24 days on 15 pregnant type 1 diabetic women. Telemonitoring of the patient data was done automatically. No major technical problems with proper operation or handling of the system was noted. Total effectiveness was 69.3 +/- 13.0% and technical effectiveness 91.5 +/- 6.1%. The efficacy of the system was not significantly influenced by patient intelligence level, education level or place of residence (p < 0.05). Significant improvement of metabolic control was noted during application of the system. In conclusion, the telematic system we developed and implemented should have a positive influence on the quality of diabetes treatment during pregnancy.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">11314810</PMID><DateCreated><Year>2001</Year><Month>04</Month><Day>20</Day></DateCreated><DateCompleted><Year>2001</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2011</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0391-3988</ISSN><JournalIssue CitedMedium="Print"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2001</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The International journal of artificial organs</Title><ISOAbbreviation>Int J Artif Organs</ISOAbbreviation></Journal><ArticleTitle>Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.</ArticleTitle><Pagination><MedlinePgn>157-63</MedlinePgn></Pagination><Abstract><AbstractText>A telematic system supporting intensive insulin treatment of pregnant type 1 diabetic out-clinic patients was implemented and technical efficiency of the system was evaluated over long-term ambulatory application. The system consists of a patient teletransmission module (PTM) and a central clinical control unit (CCU). The PTM contains a one-box blood glucose meter and electronic logbook, a modem and a dial-up or cellular phone set. The CCU consists of a PC computer with a modem and DIAPRET - an original program designed to monitor the intensive insulin treatment. The system was installed in the Clinic of Gastroenterology and Metabolic Disease, MA Warsaw and was tested for 166 +/- 24 days on 15 pregnant type 1 diabetic women. Telemonitoring of the patient data was done automatically. No major technical problems with proper operation or handling of the system was noted. Total effectiveness was 69.3 +/- 13.0% and technical effectiveness 91.5 +/- 6.1%. The efficacy of the system was not significantly influenced by patient intelligence level, education level or place of residence (p < 0.05). Significant improvement of metabolic control was noted during application of the system. In conclusion, the telematic system we developed and implemented should have a positive influence on the quality of diabetes treatment during pregnancy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ladyzyński</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw - Poland. Piotr.Ladyzynski@ibib.waw.pl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wójcicki</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Krzymień</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Blachowicz</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Jóźwicka</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Czajkowski</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Janczewska</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Karnafel</LastName><ForeName>W</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Int J Artif Organs</MedlineTA><NlmUniqueID>7802649</NlmUniqueID><ISSNLinking>0391-3988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D003922">Diabetes Mellitus, Type 1</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007004">Hypoglycemic Agents</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007328">Insulin</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011254">Pregnancy in Diabetics</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D012984">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D017216">Telemedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D014584">User-Computer Interface</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>4</Month><Day>21</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>10</Month><Day>12</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>4</Month><Day>21</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11314810</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/TelematiV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000691 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000691 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= TelematiV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:11314810
|texte= Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:11314810" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a TelematiV1
| This area was generated with Dilib version V0.6.31. |  |